Patents by Inventor Ghislaine Perrault

Ghislaine Perrault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of use and compositions of (S) (-)-amisulpride
    Patent number: 6187807
    Abstract: A composition of (S)(−)-amisulpride or a pharmaceutically acceptable salt thereof exhibit antipsychotic properties and are therefore useful in the treatment of certain mental disorders. The mental disorders include positive, negative, affective or cognitive symptoms of schizophrenia, dysthymia, autism, tardive dyskinesia induced by neuroleptics, Tourette disease, manic or depressive symptoms in patients with bipolar disorders, sudden attacks of delirium, migraine or drug addition. A composition of the D-(−)-tartrate of (S)-(−)-anisulpride is useful for the treatment of certain mental disorders.
    Type: Grant
    Filed: December 29, 1999
    Date of Patent: February 13, 2001
    Assignee: Sanofi-Synthelabo
    Inventors: Ghislaine Perrault, Hans Schoemaker, Joël Miget
  • Compositions of (S) (-)-amisulpride
    Patent number: 6169094
    Abstract: A composition is provided comprising an antipsychotic effective amount of (S)(−)-amisulpride, (S)-(−)-4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl)-2-methoxybenzamide. A preferred composition comprises the (D)-tartrate salt of (S)(−)-amisulpride. The (S)(−) enantiomer exhibits antipsychotic properties and administration of the specific enantiomer reduces adverse side effects by reducing toxicity.
    Type: Grant
    Filed: July 14, 1998
    Date of Patent: January 2, 2001
    Assignee: Sanofi-Synthelabo
    Inventors: Ghislaine Perrault, Hans Schoemaker, Jo{umlaut over (e)}l Miget